Flavonoids of herba epimedii and bone metabolism in experimental ovarian deficiency

Nutrition and Diet in Menopause

Volumn , Issue , 2013, Pages 427-439

  Wong, Man Sau ^a   Zhang, Yan ^b  

^a HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

^b UNIVERSITY OF SHANGHAI FOR SCIENCE AND TECHNOLOGY   (China)

Author keywords

Bone; Estrogen; Flavonoid; Herba epimedii; Icariin; Menopause; Osteoporosis; Ovariectomy

Indexed keywords

EID: 84897826552     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-62703-373-2_32     Document Type: Chapter

References (42)

1. Pie JE, Park JH, Park YH, et al. Effect of genistein on the expression of bone metabolism genes in ovariectomized mice using a cDNA microarray. J Nutr Biochem. 2006;17:157-64.
2. Stevenson JC. Prevention of osteoporosis: one step forward, two steps back. Menopause Int. 2011;17:137-41.
3. Reginster JY, Burlet N. Osteoporosis: a still increasing prevalence. Bone. 2006;38(Suppl):4S-9.
4. Kastner J. Chinese nutrition therapy: dietetics in traditional Chinese medicine. 2nd ed. Stuttgart: Georg Thieme; 2009.
5. Zhang Y, Wong MS, Wu CF. Anti-osteoporotic effects of medicinal herbs and their mechanisms of action. Asian J Trad Med. 2006;1:105-11.
6. Sze SC, Tong Y, Ng TB, Cheng CL, Cheung HP. Herba epimedii: anti-oxidative properties and its medical implications. Molecules. 2010;15:7861-70.
7. Guan XY, Li HF, Yang WZ, et al. HPLC-DAD-MS(n) analysis and HPLC quantitation of chemical constituents in Xian-ling-gu-bao capsules. J Pharm Biomed Anal. 2011;55:923-33.
8. Sun Y, Lee SM, Wong YM, et al. Dosing effects of an antiosteoporosis herbal formula-a preclinical investigation using a rat model. Phytother Res. 2008;22:267-73.
9. Zhang Y, Chen WF, Lai WP, Wong MS. Soy iso flavones and their bone protective effects. In flammopharmacology. 2008;16:213-5.
10. Jones G, Dwyer T, Hynes K, et al. A randomized controlled trial of phytoestrogen supplementation, growth and bone turnover in adolescent males. Eur J Clin Nutr. 2003;57:324-7.
11. Zhang Y, Li Q, Wan HY, Helferich WG, Wong MS. Genistein and a soy extract differentially affect three-dimensional bone parameters and bone-specific gene expression in ovariectomized mice. J Nutr. 2009;139:2230-6.
12. Wu T, Cui L, Zhang Z, et al. Experimental study on antagonizing action of Herba epimedii on side effects induced by glucocorticoids. China J Chin Mater Med. 1996;21:748-51.
13. Xie F, Wu CF, Lai WP, et al. The osteoprotective effect of Herba epimedii (HEP) extract in vivo and in vitro. Evid Based Complement Alternat Med. 2005;2:353-61.
14. Nian H, Xu LL, Ma MH, et al. Prevention of bone loss by aqueous extract of Epimedii sagittatum in an ovariectomized rat model of osteoporosis. J Chin Integra Med. 2006;4:628-33.
15. Jin L, Yang YQ, Wang S. Herba epimedii effect on osteoclast formation induced by RANKL and M-CSF and on the expression of FN. J Huazhong Norm Univ Nat Sci. 2009;43:640-64.
16. Levis S, Strickman-Stein N, Ganjei-Azar P, et al. Soy iso flavones in the prevention of menopausal bone loss and menopausal symptoms: a randomized, double-blind trial. Arch Intern Med. 2011;171:1363-9.
17. Chen WF, Mok SK, Wang XL, et al. Total flavonoid fraction of the Herba epimedii extract suppresses urinary calcium excretion and improves bone properties in ovariectomised mice. Br J Nutr. 2011;105:180-9.
18. Qian G, Zhang X, Lu L, et al. Regulation of Cbfa1 expression by total flavonoids of Herba epimedii. Endocr J. 2006;53:87-94.
19. Zhang G, Qin L, Hung WY, et al. Flavonoids derived from herbal Epimedium Brevicornum Maxim prevent OVX-induced osteoporosis in rats independent of its enhancement in intestinal calcium absorption. Bone. 2006;38:818-25.
20. Zhang JF, Li G, Meng CL, et al. Total flavonoids of Herba epimedii improves osteogenesis and inhibits osteoclastogenesis of human mesenchymal stem cells. Phytomedicine. 2009;16:521-9.
21. Zhang Y, Dong XL, Leung PC, Wong MS. Differential mRNA expression profiles in proximal tibia of aged rats in response to ovariectomy and low Ca diet. Bone. 2009;44:46-52.
22. Liu Y, Zang H, Zhang H, Chen J. Effect of Herba Epimedii Flavone on expression of OPG and RANKL in rat osteoblasts. J Chin Med Mater. 2005;28:1076-8.
23. Peng S, Zhang G, He Y, et al. Epimedium-derived flavonoids promote osteoblastogenesis and suppress adipogenesis in bone marrow stromal cells while exerting an anabolic effect on osteoporotic bone. Bone. 2009;45:534-44.
24. Wu MS, Zhao SZ, Li E, Bai X, Hao XH. Effect of total flavonoids of Epimedium sagittatum and its metabolites on osteoblast proliferation and function expression. Chin Pharmacol Bull. 2009;25:613-6.
25. Zhou ZZ, Luo JG, Guo BL, Kong LY. Analysis of bioactive flavonoids and resources research of main Herba epimedii species from different origins. J China Pharm Univ. 2010;41:146-50.
26. Ma HP, Ming LG, Ge BF, et al. Icariin is more potent than genistein in promoting osteoblast differentiation and mineralization in vitro. J Cell Biochem. 2011;112:916-23.
27. Zhang Y, Li XL, Yao XS, Wong MS. Osteogenic activities of genistein derivatives were in fluenced by the presence of prenyl group at ring A. Arch Pharm Res. 2008;31:1534-9.
28. Wong SP, Shen P, Lee L, Li J, Yong EL. Pharmacokinetics of prenyl flavonoids and correlations with the dynamics of estrogen action in sera following ingestion of a standardized Epimedium extract. J Pharm Biomed Anal. 2009;50:216-23.
29. Nian H, Ma MH, Nian SS, Xu LL. Antiosteoporotic activity of icariin in ovariectomized rats. Phytomedicine. 2009;16:320-6.
30. Mok SK, Chen WF, Lai WP, et al. Icariin protects against bone loss induced by oestrogen de ficiency and activates oestrogen receptor-dependent osteoblastic functions in UMR 106 cells. Br J Pharmacol. 2010;159:939-49.
31. Zhang JJ, Wen Y, Zhang GL, Xiao J. Analysis of the effects of icariin on the mice with osteoporosis through index of histomorphometry of bone. Guizhou Med J. 2010;34:404-5.
32. Wen Y, Zhang JJ, Chen XM, Ren GY, Zhang GL. Effects of icariin of examining the expression level of interleukin-6 in mice models of experimental osteoporosis. Guizhou Med J. 2010;34:781-3.
33. Wu MS, Zhao SZ, Ren LZ, Wang R, Bai X. Effects of icariin on expression of the estrogen receptor beta mRNA of bone and different hypothalamic nuclei in ovariectomy rats. Chin Pharmacol Bull. 2011;27:29-33.
34. Wu JS, Zhang Y, Wen Y, Zhang JJ. Effects of icariin on serum estradiol of ovariectomized mice. Guizhou Med J. 2010;34:79-80.
35. Zhang JF, Li G, Chan CY, et al. Flavonoids of Herba epimedii regulate osteogenesis of human mesenchymal stem cells through BMP and Wnt/beta-catenin signaling pathway. Mol Cell Endocrinol. 2010;314:70-4.
36. Zhang JF, Xie WD, Zhang YO, et al. WNT/beta-catenin signaling involved in the osteogenesis of human MSCs induced by flavonoids of Herba epimedii. Prog Modern Biomed. 2010;10:1006-8.
37. Hsieh TP, Sheu SY, Sun JS, Chen MH, Liu MH. Icariin isolated from Epimedium pubescens regulates osteoblasts anabolism through BMP-2, SMAD4, and Cbfa1 expression. Phytomedicine. 2010;17:414-23.
38. Zhao J, Ohba S, Shinkai M, Chung UI, Nagamune T. Icariin induces osteogenic differentiation in vitro in a BMPand Runx2-dependent manner. Biochem Biophys Res Commun. 2008;369:444-8.
39. Yap SP, Shen P, Li J, Lee LS, Yong EL. Molecular and pharmacodynamic properties of estrogenic extracts from the traditional Chinese medicinal herb Epimedium. J Ethnopharmacol. 2007;113:218-24.
40. Shen P, Guo BL, Gong Y, et al. Taxonomic, genetic, chemical and estrogenic characteristics of Epimedium species. Phytochemistry. 2007;68:1448-58.
41. Zhao LN. Clinical evaluation of Herba epimedii on osteoporosis. Modern J Integra Chin Trad West Med. 2003;12:922-3.
42. Zhang G, Qin L, Shi Y. Epimedium-derived phytoestrogen flavonoids exert bene ficial effect on preventing bone loss in late postmenopausal women: a 24-month randomized, double-blind and placebo-controlled trial. J Bone Miner Res. 2007;22:1072-9.